Short-Term Therapy With Rosiglitazone, a PPAR-γAgonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats

ISRN Pharmacology
doi 10.5402/2012/130347
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited


Related search